These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 19272069)

  • 1. Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators.
    Robinson M; Healey JS; Eikelboom J; Schulman S; Morillo CA; Nair GM; Baranchuk A; Ribas S; Evans G; Connolly SJ; Turpie AG
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):378-82. PubMed ID: 19272069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemorrhagic risk of different perioperative anticoagulation protocols in patients implanted with a cardiac pacemaker or defibrillator: retrospective analysis in patients implanted in a community hospital].
    Amara W; Ben Youssef I; Kamel J; Ghrissi I; Faron M; Khouadja A; Sergent J
    Ann Cardiol Angeiol (Paris); 2009 Nov; 58(5):265-71. PubMed ID: 19833318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
    Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
    J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry).
    Spyropoulos AC; Turpie AG; Dunn AS; Kaatz S; Douketis J; Jacobson A; Petersen H;
    Am J Cardiol; 2008 Oct; 102(7):883-9. PubMed ID: 18805116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.
    Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD
    Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery.
    Douketis JD; Woods K; Foster GA; Crowther MA
    Thromb Haemost; 2005 Sep; 94(3):528-31. PubMed ID: 16268467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial.
    Schulman S; Healey JS; Douketis JD; Delaney J; Morillo CA
    Thromb Res; 2014 Oct; 134(4):814-8. PubMed ID: 25127655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of hematoma complications after device implant in the clopidogrel era.
    Kutinsky IB; Jarandilla R; Jewett M; Haines DE
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):312-8. PubMed ID: 20558847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
    Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
    Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Half-dose enoxaparin vs. full-dose enoxaparin for postoperative bridging therapy in patients after cardiac surgery: which dose regimen should be preferred?
    Weiss A; Brose S; Ploetze K; Matschke K
    Clin Hemorheol Microcirc; 2013 Jan; 54(3):249-58. PubMed ID: 23648452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgery.
    Bar-Yosef S; Cozart HB; Phillips-Bute B; Mathew JP; Grocott HP
    Can J Anaesth; 2007 Feb; 54(2):107-13. PubMed ID: 17272249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients.
    Hammerstingl C; Omran H
    Europace; 2011 Sep; 13(9):1304-10. PubMed ID: 21508005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative bridging therapy with low molecular weight heparin for patients with inherited thrombophilia and antiphospholipid syndrome on long-term acenokumarol therapy.
    Wiszniewski A; Szopiński P; Ratajczak J; Bilski R; Bykowska K
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):34-9. PubMed ID: 21076281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients.
    Seshadri N; Goldhaber SZ; Elkayam U; Grimm RA; Groce JB; Heit JA; Spinler SA; Turpie AG; Bosker G; Klein AL
    Am Heart J; 2005 Jul; 150(1):27-34. PubMed ID: 16084147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation.
    Thal S; Moukabary T; Boyella R; Shanmugasundaram M; Pierce MK; Thai H; Goldman S
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):385-8. PubMed ID: 20059711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robotic-assisted radical prostatectomy in patients receiving chronic anticoagulation therapy: role of perioperative bridging.
    Krane LS; Laungani R; Satyanarayana R; Kaul S; Bhandari M; Peabody JO; Menon M
    Urology; 2008 Dec; 72(6):1351-5. PubMed ID: 19041033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of a portable international normalized ratio monitor for patients receiving a low molecular weight heparin as a bridge pending full oral anticoagulant efficacy.
    Meurin P; Tabet JY; Monchi M; Weber H; Fabre C; Gibier B; Renaud N; Driss AB
    Thromb Res; 2010 Feb; 125(2):192-5. PubMed ID: 19942256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant effect at the time of epidural catheter removal in patients receiving twice-daily or once-daily low-molecular-weight heparin and continuous epidural analgesia after orthopedic surgery.
    Douketis JD; Kinnon K; Crowther MA
    Thromb Haemost; 2002 Jul; 88(1):37-40. PubMed ID: 12152674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices.
    Cano O; Muñoz B; Tejada D; Osca J; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A
    Heart Rhythm; 2012 Mar; 9(3):361-7. PubMed ID: 22001709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.
    Ghanbari H; Feldman D; Schmidt M; Ottino J; Machado C; Akoum N; Wall TS; Daccarett M
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):400-6. PubMed ID: 20180915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.